GlassScriptPhysician profile
Vadim Gushchin
NPI 1427054568
$3,829.35
in general payments reported to CMS, 2019-2025
34 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $81.70 · 2021: $553 · 2022: $553 · 2023: $758 · 2024: $854 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $840.11 | 2021-2025 | Enseal, Echelon Flex, Enseal X1 |
| Abbvie INC. | $492.24 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $401.64 | 2019-2023 | Opdualag, Opdivo |
| Intera Oncology, INC | $228.15 | 2024 | Intera |
| Eisai INC. | $197.01 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $177.87 | 2019-2024 | Keytruda |
| Medical Device Business Services, INC. | $176.52 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $147.29 | 2021-2025 | Libtayo |
| Medtronic, INC. | $110.36 | 2021-2024 | Signia, Valleylab Ft10 |
| Novartis Pharmaceuticals Corporation | $105.06 | 2019-2025 | |
| Baxter Healthcare | $96.09 | 2023-2024 | Perclot |
| Genzyme Corporation | $79.85 | 2019-2021 | |
| Histosonics, INC. | $76.78 | 2024 | |
| Hologic Sales and Service, LLC | $73.71 | 2022-2024 | Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $72.08 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $65.78 | 2019-2025 | Smart Port Ct |
| Springworks Therapeutics, INC. | $50.61 | 2024-2025 | Ogsiveo |
| Astrazeneca Pharmaceuticals LP | $46.08 | 2019-2023 | Lynparza |
| Emd Serono, INC. | $44.34 | 2019 | |
| Covidien LP | $42.74 | 2019 | |
| Janssen Biotech, INC. | $34.30 | 2019-2023 | |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.29 | 2023 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $23.15 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Foundation Medicine, INC. | $22.96 | 2023 | Foundationone Cdx |
| Avanos Medical | $22.11 | 2019 | |
| Tei Biosciences INC | $20.94 | 2019 | |
| Getinge USA Sales, LLC | $20.75 | 2025 | Maquet Powerled II |
| Seagen INC. | $20.06 | 2022 | |
| Shire North American Group INC | $18.34 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $17.31 | 2025 | |
| Amgen INC. | $17.20 | 2019 | |
| Puma Biotechnology, INC. | $16.28 | 2019 | |
| Clovis Oncology, INC. | $16.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Gushchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.